Thomas Shaffer
Overview
Explore the profile of Thomas Shaffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pollack L, Chang A, Lee J, Shaffer T, Wall H, Brawner C, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e037811.
PMID: 39989369
Background: Cardiac rehabilitation (CR) can improve cardiovascular health. We identified whether CR participation was associated with fewer subsequent inpatient hospitalizations and emergency department visits and less Medicare and out-of-pocket expenditures,...
2.
Brooks A, Vajente G, Yamamoto H, Abbott R, Adams C, Adhikari R, et al.
Appl Opt
. 2021 May;
60(13):4047-4063.
PMID: 33983346
Small, highly absorbing points are randomly present on the surfaces of the main interferometer optics in Advanced LIGO. The resulting nanometer scale thermo-elastic deformations and substrate lenses from these micron-scale...
3.
Levenbrown Y, Hossain M, Keith J, Burr K, Hesek A, Shaffer T
Intensive Care Med Exp
. 2020 Jul;
8(1):36.
PMID: 32712733
Background: Positive end-expiratory pressure (PEEP) is used to optimize oxygenation by preventing alveolar collapse. However, PEEP can potentially decrease cardiac output through cardiopulmonary interactions. The effect of PEEP on cardiac...
4.
Ritchey M, Maresh S, McNeely J, Shaffer T, Jackson S, Keteyian S, et al.
Circ Cardiovasc Qual Outcomes
. 2020 Jan;
13(1):e005902.
PMID: 31931615
Background: Despite cardiac rehabilitation (CR) being shown to improve health outcomes among patients with heart disease, its use has been suboptimal. In response, the Million Hearts Cardiac Rehabilitation Collaborative developed...
5.
Costa J, Zhu Y, Cox T, Fawcett P, Shaffer T, Alapati D
Inflammation
. 2018 Apr;
41(4):1250-1258.
PMID: 29656317
Pulmonary hypertension in the neonate requires treatment with oxygen and positive pressure ventilation, both known to induce lung injury. The direct response of pulmonary artery smooth muscle cells, the most...
6.
Zuckerman I, Davidoff A, Erten M, Stuart B, Shaffer T, Dougherty J, et al.
Support Care Cancer
. 2014 Mar;
22(8):2185-95.
PMID: 24659243
Purpose: The study objective was to provide population-based estimates of supportive care medication (SCM) use among Medicare beneficiaries with cancer and determine factors related to SCM receipt. Methods: This retrospective...
7.
Erten M, Davidoff A, Zuckerman I, Shaffer T, Dougherty J, Ke X, et al.
Value Health
. 2014 Jan;
17(1):15-21.
PMID: 24438713
Objectives: To examine whether patients with newly diagnosed cancer respond differently to supplemental coverage than the general Medicare population. Methods: A cohort of newly diagnosed cancer patients (n = 1,799)...
8.
Stuart B, Davidoff A, Erten M, Gottlieb S, Dai M, Shaffer T, et al.
Health Serv Res
. 2013 Jun;
48(6 Pt 1):1960-77.
PMID: 23742013
Objective: Assess impact of Medicare Part D benefit phases on adherence with evidence-based medications after hospitalization for an acute myocardial infarction. Data Source: Random 5 percent sample of Medicare beneficiaries....
9.
Davidoff A, Erten M, Shaffer T, Shoemaker J, Zuckerman I, Pandya N, et al.
Cancer
. 2012 Dec;
119(6):1257-65.
PMID: 23225522
Background: There is increasing concern regarding the financial burden of care on cancer patients and their families. Medicare beneficiaries often have extensive comorbidities and limited financial resources, and may face...
10.
Davidoff A, Shaffer T, Erten M, Shoemaker J, Zuckerman I, Pandya N, et al.
Med Care
. 2012 Dec;
51(4):351-60.
PMID: 23222498
Background: Oral antineoplastic drugs, not generally covered by Medicare Part B, have assumed an increasingly important role in cancer treatment. Objective: We examined use and spending on infused/injected (Part B...